Disease Processes
Showing 9976 - 10000 of >10,000
Multi-Ethnic Study of Atherosclerosis (MESA)
Active, not recruiting
- Atherosclerosis
- +10 more
- (no location specified)
May 3, 2022
Measuring Parkinson's Disease With Tear Fluid
Completed
- Idiopathic Parkinson Disease
-
Los Angeles, CaliforniaUniversity of Southern California
May 5, 2022
Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS)
Recruiting
- Amyotrophic Lateral Sclerosis (ALS)
-
Pozzilli, ItalyIRCCS Neuromed
May 18, 2022
Asthma, Rhinitis, Allergic Trial in Porto (Component resolved diagnosis, Standard diagnosis)
Recruiting
- Asthma
- Rhinitis, Allergic
- Component resolved diagnosis
- Standard diagnosis
-
Porto, PortugalFaculty of Medicine Porto University/Centro Hospitalar de São Jo
Nov 14, 2022
Surgical Planning With Patient-specific Pancreaticobiliary
Completed
- Surgical Injury
- survey
-
Izmir, Bornova, TurkeyEge University, Faculty of Medicine
May 29, 2020
Crohn Disease, Nutrient; Excess, Remission/Regression Trial in Duzce (EEN (Nestle Modulen®), Standart of care)
Recruiting
- Crohn Disease
- +2 more
- EEN (Nestle Modulen®)
- Standart of care
-
Duzce, TurkeyDuzce University School of Medicine
Oct 15, 2022
Profile of Dysphagia in Myotonic Dystrophy Type 1 (DM1)
Not yet recruiting
- Myotonic Dystrophy 1
- Dysphagia, Oropharyngeal
- (no location specified)
May 9, 2023
Perennial Allergic Rhinitis Trial in Tampa (pine cone extract, )
Active, not recruiting
- Perennial Allergic Rhinitis
- pine cone extract
- placebo
-
Tampa, FloridaUsf Asthma Allergy and Immunology Cru
Nov 14, 2022
Dementia, Mild Cognitive Impairment, Alzheimer Trial in Berkeley (In-Home Technology System, Limited In-Home Technology)
Not yet recruiting
- Dementia
- +2 more
- In-Home Technology System
- Limited In-Home Technology
-
Berkeley, CaliforniaUniversity of California, Berkeley
May 17, 2022
Breast Cancer, PI3K, Alpelisib Trial in France (Alpelisib, Chemotherapy)
Active, not recruiting
- Breast Cancer, PI3K, Alpelisib
-
Angers, France
- +13 more
Mar 8, 2022
Breast Tumors, Chemotherapeutic Toxicity Trial in Quebec City (Application)
Recruiting
- Breast Neoplasms
- Chemotherapeutic Toxicity
- Application
-
Quebec City, Quebec, CanadaSt-Sacrement Hospital
Feb 24, 2023
Postoperative Pain Trial (Single obturation technique, lateral condensation technique, Vertical condensation technique)
Not yet recruiting
- Postoperative Pain
- Single obturation technique
- +2 more
- (no location specified)
Nov 24, 2023
Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)
Recruiting
- Chronic Graft Versus Host Disease
- Belumosudil
- +3 more
-
Duarte, CaliforniaCity of Hope Site Number : 8400001
Nov 23, 2023
Polycystic Kidney Disease Data Repository
Recruiting
- Polycystic Kidney Disease
-
New York, New YorkThe Rogosin Institute
Feb 28, 2022
Insights Into Microbiome and Environmental Contributions to
Recruiting
- Genetic Disease
- Genomics
-
Bethesda, Maryland
- +3 more
Apr 7, 2022
ADHD (ADHD), Attention Deficit Disorder (ADD) Trial in Asse (Home-based transcranial direct current (tDCS) device)
Recruiting
- Attention Deficit Hyperactivity Disorder (ADHD)
- Attention Deficit Disorder (ADD)
- Home-based transcranial direct current (tDCS) device
-
Asse, Vlaams-Brabant, BelgiumOLVZ Asse
Nov 11, 2020
Upadacitinib in Adult Hungarian Moderate to Severe Rheumatoid
Recruiting
- Rheumatoid Arthritis
-
Szeged, Csongrad, Hungary
- +7 more
Nov 9, 2022
Metastatic Colorectal Cancer, KRAS Gene Mutation Trial in United States (Onvansertib, Bevacizumab, FOLFIRI)
Active, not recruiting
- Metastatic Colorectal Cancer
- KRAS Gene Mutation
- Onvansertib
- +2 more
-
Phoenix, Arizona
- +6 more
Nov 10, 2022
NSCLC (NSCLC) Trial in Worldwide (Tislelizumab, Docetaxel, Sitravatinib)
Recruiting
- Non-Small Cell Lung Cancer (NSCLC)
- Tislelizumab
- +2 more
-
Tucson, Arizona
- +112 more
Nov 9, 2022
Neurofibromatosis 1 Trial in Baltimore, Redwood City
Recruiting
- Neurofibromatosis 1
-
Baltimore, California
- +1 more
Aug 17, 2022
LITMUS Imaging Study
Recruiting
- NAFLD
- +4 more
-
San Antonio, Texas
- +17 more
Jul 26, 2022
Crohn Disease Trial (selective intensive induction therapy based on ustekinumab clinical decision-making tools)
Not yet recruiting
- Crohn Disease
- selective intensive induction therapy based on ustekinumab clinical decision-making tools
- (no location specified)
May 6, 2023
Rosacea Trial in Jakarta, Depok (Metronidazole 1% Cream,Top, Placebo)
Not yet recruiting
- Rosacea
- Metronidazole 1% Cream,Top
- Placebo
-
Jakarta, DKI Jakarta, Indonesia
- +1 more
May 14, 2023